GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Molecure MOC.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

5.45

-1.98%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in PLN, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−PLN 15.7m

FY2016FY2025

Free cash flow

−PLN 19.4m

FY2016FY2025

Shareholders' equity

PLN 87.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue—PLN 2.9mPLN 100PLN 7.5mPLN 400PLN 122.9mPLN 2,807PLN 3,000PLN 6,000PLN 6,600
Gross profit—−PLN 489,909−PLN 4.1m−PLN 21,328−PLN 2.8mPLN 84.5m−PLN 144,055−PLN 146,706−PLN 98,936−PLN 50,243
Research and developmentPLN 1.3mPLN 2.4mPLN 2.7mPLN 11.6mPLN 2.6mPLN 38.3m—PLN 126,133—PLN 1.5m
Operating income−PLN 22.0m−PLN 33.6m−PLN 32.1m−PLN 43.9m−PLN 13.8mPLN 73.7m−PLN 4.8m−PLN 5.1m−PLN 2.6m−PLN 2.5m
Net income−PLN 15.7m−PLN 31.3m−PLN 28.4m−PLN 13.5m−PLN 13.6mPLN 68.0m−PLN 4.2m−PLN 3.8m−PLN 2.4m−PLN 2.4m
Diluted earnings per share-0.76-1.55-1.69-0.97-0.974.87-0.30-0.28-0.21-0.21

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsPLN 94.4mPLN 113.7mPLN 112.3mPLN 138.1mPLN 151.6mPLN 153.5mPLN 85.7mPLN 86.0mPLN 34.6mPLN 15.5m
Cash and short-term investmentsPLN 16.3mPLN 18.2mPLN 64.0mPLN 65.6mPLN 102.0mPLN 120.5mPLN 34.0mPLN 51.9mPLN 13.2mPLN 2.5m
Total liabilitiesPLN 7.0mPLN 10.3mPLN 11.3mPLN 11.6mPLN 10.4mPLN 10.1mPLN 6.6mPLN 4.1mPLN 4.8mPLN 2.5m
DebtPLN 5.3mPLN 7.2mPLN 7.1mPLN 6.4mPLN 6.0mPLN 5.2mPLN 3.8m———
Shareholders' equityPLN 87.4mPLN 103.4mPLN 100.9mPLN 126.4mPLN 141.1mPLN 147.1mPLN 79.1mPLN 81.9mPLN 29.7mPLN 13.0m
Shares outstanding21m20m17m14m14m14m14m14m12m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−PLN 19.4m−PLN 57.0m−PLN 23.3m−PLN 10.2m−PLN 13.5mPLN 57.4m−PLN 7.1m−PLN 4.9m−PLN 599,630−PLN 1.4m
Capital spending−PLN 3−PLN 23.8m−PLN 362,233−PLN 33.6m−PLN 18.8m−PLN 2.1m−PLN 34.9m−PLN 27.4m−PLN 24.0m−PLN 14.6m
Free cash flow−PLN 19.4m−PLN 80.8m−PLN 23.7m−PLN 43.8m−PLN 32.3mPLN 55.3m−PLN 42.0m−PLN 32.3m−PLN 24.6m−PLN 16.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenuePLN 156,280PLN 12,000——PLN 3.0mPLN 597,713PLN 1.8mPLN 774,718
Gross profit−PLN 3.0m−PLN 3.5m——PLN 2.7m−PLN 686,495−PLN 1.1m−PLN 716,971
Operating income−PLN 3.7m−PLN 4.2m−PLN 4.1m−PLN 5.5m−PLN 3.8m−PLN 5.5m−PLN 10.6m−PLN 6.4m
Net income−PLN 2.2m−PLN 4.1m−PLN 1.7m−PLN 5.3m−PLN 3.5m−PLN 5.2m−PLN 10.5m−PLN 6.3m
Diluted earnings per share-0.10-0.17-0.08-0.26-0.17-0.25-0.52-0.31
Cash from operations—−PLN 2.0m−PLN 3.0m−PLN 6.0m−PLN 35.0mPLN 26.0m−PLN 34.0m−PLN 6.0m
Capital spending—————−PLN 3.0m−PLN 5.0m−PLN 3.0m
Free cash flow—————PLN 23.0m−PLN 39.0m−PLN 9.0m
Total assetsPLN 112.6mPLN 109.4mPLN 94.4mPLN 97.2mPLN 103.3mPLN 107.4mPLN 113.7mPLN 87.7m
Cash and short-term investmentsPLN 24.9mPLN 8.1mPLN 16.3mPLN 22.5mPLN 32.5mPLN 40.7mPLN 18.2mPLN 28.6m
DebtPLN 1.8mPLN 1.4mPLN 2.0mPLN 2.1mPLN 2.1mPLN 1.6mPLN 2.2mPLN 1.6m
Shareholders' equityPLN 101.3mPLN 102.0mPLN 87.4mPLN 89.4mPLN 94.7mPLN 98.2mPLN 103.4mPLN 80.1m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-20.5%—39.4%
Net income5.0%—39.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-8.7-6.5-11.6-14.8-21.25.7-17.7-28.5
Price to sales—69.9—26.6—3.2——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.